Insights

Global collaboration Chugai Pharma USA supports planning and execution of global and U.S. clinical programs for Chugai-originated, innovative drug candidates, indicating opportunity to align BD efforts with cross-border regulatory and clinical development activities.

R&D and tech focus Strong emphasis on R&D and antibody technologies, with a tech stack including gPROMS, Kubernetes, AWS services and data analytics; potential sales angle for CRO/CDMO tech enablement, analytics platforms, and manufacturing automation solutions.

Manufacturing excellence Recent recognition for manufacturing automation at the FJ3 API production facility (ISPE FOYA Honorable Mention) signals openness to advanced manufacturing technologies, process optimization services, and scalable API production partnerships.

Financial potential Parent company reporting solid earnings and substantial R&D activity, with US subsidiary positioned to pursue U.S. clinical programs; opportunity to propose early-access programs, rare-disease or oncology partnerships, and co-development financing options.

Strategic partnerships Chugai tends to partner for late-stage development outside Japan and seeks collaboration with Roche or other third parties; identify opportunities for strategic co-development, licensing, or Roche-aligned partnerships to accelerate market access.

Similar companies to Chugai Pharma USA, Inc.

Adaptimmune
140$50M - $100M
Atara Biotherapeutics
104$1M - $10M
Roche
107K$10B+
AVROBIO
16$10M - $25M
Epizyme
246$10M - $25M
Bio-Techne
3K$1B - $10B
Genentech
18K$10B+
iTeos Therapeutics
33$1M - $10M
Gossamer Bio
137$50M - $100M
aTyr Pharma
74<$1M
EUSA Pharma
201$25M - $50M

Chugai Pharma USA, Inc. Tech Stack

Chugai Pharma USA, Inc. uses 8 technology products and services including MATLAB, iCIMS, Microsoft Power Platform, and more. Explore Chugai Pharma USA, Inc.'s tech stack below.

MATLAB
Advanced Analytics And Data Science
iCIMS
Applicant Tracking Systems
Microsoft Power Platform
Business Intelligence
GitHub
Communication And Collaboration
HashiCorp Terraform
Configuration Management
SAP
Customer Relationship Management
Azure Active Directory
Identity And Access Management
Microsoft Active Directory
Identity And Access Management

Media & News

Chugai Pharma USA, Inc.'s Email Address Formats

Chugai Pharma USA, Inc. uses at least 4 email formats:

Chugai Pharma USA, Inc. Email Formats	Example	Percentage
First.Last@chugai-pharm.co.jp	John.Doe@chugai-pharm.co.jp	77%
FirstLast@chugai-pharm.co.jp	JohnDoe@chugai-pharm.co.jp	19%
Last.First@chugai-pharm.co.jp	Doe.John@chugai-pharm.co.jp	3%
FirstLas@chugai-pharm.co.jp	JohnDoe@chugai-pharm.co.jp	1%

Frequently Asked Questions

What is Chugai Pharma USA, Inc.'s phone number?

You can contact Chugai Pharma USA, Inc.'s main corporate office by phone at

+81-550-87-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Chugai Pharma USA, Inc.'s official website and social media links?

Chugai Pharma USA, Inc.'s official website is chugai-pharm.co.jp and has social profiles on LinkedIn.

How much revenue does Chugai Pharma USA, Inc. generate?

As of August 2026, Chugai Pharma USA, Inc.'s annual revenue is estimated to be $100M - $250M.

What is Chugai Pharma USA, Inc.'s NAICS code?

Chugai Pharma USA, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Chugai Pharma USA, Inc. have currently?

As of August 2026, Chugai Pharma USA, Inc. has approximately 221 employees across 4 continents, including Asia, North America and Europe. Key team members include Chief Scientist: K. O., Head Of Clinical Pharmacology: K. T. and Department Head: T. T. Explore Chugai Pharma USA, Inc.'s employee directory with LeadIQ.

What industry does Chugai Pharma USA, Inc. belong to?

Chugai Pharma USA, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Chugai Pharma USA, Inc. use?

Chugai Pharma USA, Inc.'s tech stack includes MATLAB, iCIMS, Microsoft Power Platform, GitHub, HashiCorp Terraform, SAP, Azure Active Directory and Microsoft Active Directory.

What is Chugai Pharma USA, Inc.'s email format?

Chugai Pharma USA, Inc.'s email format typically follows the pattern of First.Last@chugai-pharm.co.jp. Find more Chugai Pharma USA, Inc. email formats with LeadIQ.

Chugai Pharma USA, Inc.

Q: What is Chugai Pharma USA, Inc.'s phone number?

You can contact Chugai Pharma USA, Inc.'s main corporate office by phone at +81-550-87-****.

Q: What is Chugai Pharma USA, Inc.'s official website and social media links?

Chugai Pharma USA, Inc.'s official website is chugai-pharm.co.jp. Chugai Pharma USA, Inc. has social profiles on LinkedIn.

Q: How much revenue does Chugai Pharma USA, Inc. generate?

Chugai Pharma USA, Inc.'s annual revenue is estimated to be $100M - $250M.

Q: How many employees does Chugai Pharma USA, Inc. have currently?

Chugai Pharma USA, Inc. has approximately 221 employees.

Q: What industry does Chugai Pharma USA, Inc. belong to?

Chugai Pharma USA, Inc. operates in the Pharmaceutical Manufacturing industry.

Q: What technology does Chugai Pharma USA, Inc. use?

Chugai Pharma USA, Inc.'s tech stack includes Qlik Talend Cloud, VMware, Angular, SQL, Google BigQuery.

Q: What is Chugai Pharma USA, Inc.'s NAICS code?

Chugai Pharma USA, Inc.'s NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingJapan201-500 Employees

Chugai Pharma USA, Inc. operates as a Berkeley Heights, New Jersey-based subsidiary of Chugai Pharmaceutical Co., Ltd., the Tokyo-based firm that is part of the Roche Group. CPUSA supports the planning and execution of global and U.S. clinical programs for Chugai-originated, innovative drug candidates.

Chugai positions itself in the pharmaceutical industry with strengths in biotechnology and prescription medicines, concentrating on oncology, bone and joint diseases, renal disorders, and other areas with unmet medical needs. For late-stage development and marketing outside Japan, South Korea, and Taiwan, the company seeks partnerships with Roche or other third parties. Recent reports describe a collaboration with Gero's discovery engine to identify targets for Chugai's drug candidates.